Halogenoderma and monoclonal gammopathy.
Cordoliani
F
F
Rybojad
M
M
Morel
P
P
Puissant
A
A
D001965:Bromides / Q000009:adverse effects*; D002125:Calcium Gluconate / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006219:Halogens / Q000009:adverse effects; D006801:Humans; D006942:Hypergammaglobulinemia / Q000150:complications*; D007074:Immunoglobulin G; D007145:Immunoglobulin kappa-Chains; D008875:Middle Aged; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced*
D001965:Bromides; D006219:Halogens; D007074:Immunoglobulin G; D007145:Immunoglobulin kappa-Chains; C018239:bromolactobionic acid; D002125:Calcium Gluconate